Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.67B
| $356K | ﹤0.01% |
4,100
-2,200
| -35% | -$201K |
|
|
MAPS
3052
DELISTED
WM TECHNOLOGY INC A
MAPS
| $356K | ﹤0.01% |
425,300
-323,300
| -43% | -$264K |
|
3053
Pacer Data & Infrastructure Real Estate ETF
SRVR
$389M
| $356K | ﹤0.01% |
12,200
-500
| -4% | -$14.5K |
|
3054
Pagaya Technologies
PGY
$1.79B
| $354K | ﹤0.01% |
+21,098
| New | +$263K |
|
|
LSXMA
3055
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $354K | ﹤0.01% |
14,699
-161,551
| -92% | -$3.44M |
|
|
AFMD
3056
DELISTED
Affimed
AFMD
| $353K | ﹤0.01% |
58,960
-81,864
| -58% | -$656K |
|
|
BLFY
3057
DELISTED
Blue Foundry Bancorp
BLFY
| $353K | ﹤0.01% |
34,900
+1,200
| +4% | +$11.6K |
|
|
EGIO
3058
DELISTED
Edgio, Inc. Common Stock
EGIO
| $353K | ﹤0.01% |
13,081
+4,104
| +46% | +$97K |
|
3059
Immunome
IMNM
$3B
| $352K | ﹤0.01% |
44,500
+15,600
| +54% | +$85.3K |
|
3060
Peoples Bancorp
PEBO
$1.49B
| $352K | ﹤0.01% |
13,240
-27,025
| -67% | -$705K |
|
3061
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $352K | ﹤0.01% |
+6,400
| New | +$336K |
|
3062
Zai Lab
ZLAB
$2.92B
| $352K | ﹤0.01% |
12,700
-24,100
| -65% | -$788K |
|
3063
Santander
BSBR
$43.2B
| $351K | ﹤0.01% |
+55,200
| New | +$322K |
|
3064
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $351K | ﹤0.01% |
+5,400
| New | +$337K |
|
3065
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$926M
| $349K | ﹤0.01% |
8,099
-17,001
| -68% | -$739K |
|
3066
LifeMD
LFMD
$167M
| $348K | ﹤0.01% |
79,971
+63,471
| +385% | +$141K |
|
3067
FVCBankcorp
FVCB
$339M
| $347K | ﹤0.01% |
32,175
+900
| +3% | +$8.97K |
|
|
LND
3068
BrasilAgro
LND
$357M
| $347K | ﹤0.01% |
66,912
-16,488
| -20% | -$79.5K |
|
3069
MaxCyte
MXCT
$149M
| $347K | ﹤0.01% |
75,700
-25,500
| -25% | -$117K |
|
3070
Lisata Therapeutics
LSTA
$10.2M
| $345K | ﹤0.01% |
93,322
+900
| +1% | +$3.27K |
|
3071
Xtrackers S&P 500 ESG ETF
SNPE
$2.8B
| $345K | ﹤0.01% |
+8,500
| New | +$326K |
|
|
PHX
3072
DELISTED
PHX Minerals
PHX
| $343K | ﹤0.01% |
110,032
-133,453
| -55% | -$379K |
|
3073
Ribbon Communications
RBBN
$377M
| $342K | ﹤0.01% |
122,412
+81,512
| +199% | +$226K |
|
3074
Comscore
SCOR
$91.6M
| $342K | ﹤0.01% |
21,097
+3,465
| +20% | +$66.3K |
|
3075
Celcuity
CELC
$4.22B
| $341K | ﹤0.01% |
31,056
+2,200
| +8% | +$22.9K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.